The daily Covid-19 infections made a new record in Bangladesh with the authorities concerned reporting 7,626 cases on Wednesday.
On the other hand, the day's coronavirus death toll slightly declined to 63 from the previous day's 66, according to the Directorate General of Health Services (DGHS)
With the latest daily count, the total fatalities from coronavirus reached 9,447 in Bangladesh since the deadly virus was detected first in the country in March last year.
According to a DGHS press release, a total of 34,630 samples were tested, while some 34,668 samples were collected across the country during the past 24 hours until 8:00 am on Wednesday.
The Covid-19 test positivity rate slightly inched up to 22.02 per cent on the day from the previous day's 21.02 per cent.
A total of 3,256 people recovered from Covid-19 during the last 24-hour reporting time, and the rate of recovery was 85.19 per cent, the DGHS press release added.
On the other hand, the rate of fatalities from Covid-19 slightly fell to 1.43 per cent from 1.44 per cent on Tuesday.
According to the official data, the total coronavirus cases reached 6,59,278 in Bangladesh until April 7, and of them 5,61,639 recovered from the deadly disease.
Over 4.88 million samples have, so far, been tested in the country since March last, the DGHS figures showed.
Meanwhile, some 13,028 people received the first dose of Covid-19 vaccine across the country on Wednesday.
With the latest figure, the government has vaccinated nearly 5.57 million people throughout the country since the mass vaccination programme was launched on February 7.
Of the total, over 3.45 million were male and nearly 2.12 million were female, according to the DGHS vaccine-related data.
Over 6.97 million people have got registered for receiving Covid-19 vaccine until 5:30 pm on April 07.
Administration of the second dose of Covid-19 vaccine is set to begin from today (April 08), as scheduled earlier by the government.
Simultaneously, administering the first dose of vaccine will continue across the country amid doubts over availability of timely supply of the same from India's Serum Institute.
© 2024 - All Rights with The Financial Express
